HACKENSACK, N.J., Nov. 21, 2025 /PRNewswire/ — Investigators from Hackensack Meridian John Theurer Cancer Center (JTCC)—a leading research partner of the NCI-designated Lombardi Comprehensive Cancer ...
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access scheme ...
We earn a commission for products purchased through some links in this article. ©2025 Hearst UK is the trading name of the National Magazine Company Ltd, 30 Panton ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback